Weekly Twitter Roundup

Posted by Dan Vorhaus on May 7, 2010

Each week there are a number of stories and developments that, for one reason or another, don’t find their way into a full-length posting on the Genomics Law Report. Here’s a recap of what I was Tweeting this week @genomicslawyer:

$MYGN earnings miss estimates, shares fall & $MYGN begins stock buyback: http://bit.ly/bc2zLv Up next: Bilski SC decision
RT @jamie_heywood: I was just asked to download my genome and email it and it only took me 3 min.
RT @FierceBiotech: Burrill: We need to start understanding patients, not just molecules. #bio2010
GLR Post: Mapping the Personal Genomics Landscape http://bit.ly/doQp9A
Government-led, sector-specific (clean energy) approach to addressing patent confusion: http://bit.ly/dls3ka (via @NatureNews)
#BIO2010 Panel on Comparative Effectiveness Research Notes “Silver Lining” of Personalized Medicine http://bit.ly/drEbyQ by @crossborderbio
Into the Final Stretch: Surveying Bilski’s Treatment in the Lower Courts: http://bit.ly/9KShMZ (HT @BiotechPatent)
Illumina pushing into molecular Dx with 510(k) approval for BeadXpress (via @GenomeWeb_News): http://bit.ly/cUZydM
RT @dgmacarthur, @nanopore: NHGRI $0.5 bn request “This isn’t sci fi; this is the future NHGRI is working to create” http://bit.ly/nhgri
“What a shoddy piece of work is man,” by @NatureNews, on our flawed genome & intelligent design: http://bit.ly/9GftLo (HT @nanopore)
Microsoft Biology Foundation aims to be the “Swiss Army knife of bioinformatics” (by @ldtimmerman): http://bit.ly/b7eYbg
Last tweet: I support genetics education, but doubt athletic traits are easier to study than disease. Plus, how do they ignore GINA?
RT @Scitable: Exploring genetics of professional athletes http://bit.ly/dgtMW1
Privacy implications of linking statewide Rx monitoring databases to identify, control drug abuse (via AP): http://bit.ly/d4HZub
“The Genome Pioneers” @emilysinger does a nice job picking out themes from #GET2010: http://bit.ly/aKtPzZ
RT @FierceBiotech: E&Y: In 2009, 14% of biotech companies closed their doors. Far less than the 25% to 33% expected. #bio2010
RT @dgmacarthur: Big competition for @23andMe’s genealogy market. RT @blaine_5: FTDNA launches Family Finder: http://tinyurl.com/2538374
RT @dgmacarthur: RT @j_timmer: Ok, my latest article on DNA sequencing tech is out: http://arst.ch/jie This time up, 454 and Ion Torrent.
Surprisingly similar graphics from @AlioGenetics (http://bit.ly/9srj16) and @23andMe (http://bit.ly/MCkXf) HT @thinkgene
RT @jdudley Totally humbled to get positive comments from @carlzimmer on figure I created for Steve Quake genome paper: http://bit.ly/aBYq2C
RT @EdwardWinstead: What can you learn from a whole genome sequence? http://bit.ly/cwoHid interesting analysis by @dgmacarthur
Genomes, cool conferences, & behavioral genes by @David_Dobbs: http://bit.ly/b25Vqj Another great #GET2010 recap
A Day Among the Genomes. Tremendous account of #GET2010 from @carlzimmer: http://bit.ly/9sHXg6
How personal genomics could change healthcare: http://bit.ly/9u9SUf (by @emilysinger, HT @ahier)